Orthofix Medical Inc. Operating Expenses
Orthofix Medical Inc. (OFIX) reported Operating Expenses of $10.89 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2024-11-07
- Orthofix Medical Inc. operating expenses for the quarter ending 2024-09-30 was $10.89M, a 14.00% increase year-over-year.
- Orthofix Medical Inc. operating expenses for the quarter ending 2024-06-30 was $11.23M, a 0.27% increase year-over-year.
- Orthofix Medical Inc. operating expenses for the quarter ending 2023-09-30 was $9.55M.
- Orthofix Medical Inc. operating expenses for the quarter ending 2023-06-30 was $11.20M.
- Orthofix Medical Inc. operating expenses for fiscal 2019 was $378.13M, a 15.88% increase from fiscal 2018.
- Orthofix Medical Inc. operating expenses for fiscal 2018 was $326.32M, a 8.78% increase from fiscal 2017.
- Orthofix Medical Inc. operating expenses for fiscal 2017 was $299.98M, a 0.30% decline from fiscal 2016.
- Orthofix Medical Inc. operating expenses for fiscal 2016 was $300.87M, a 0.05% increase from fiscal 2015.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $10.89M 10-Q · filed 2024-11-07 | $22.12M derived: sum of 2 quarters · filed 2024-11-07 | $32.85M 10-Q · filed 2024-11-07 | |||||
| 2024-06-30 | $11.23M 10-Q · filed 2024-08-06 | $21.97M 10-Q · filed 2024-08-06 | ||||||
| 2023-09-30 | $9.55M 10-Q · filed 2024-11-07 | $20.75M derived: sum of 2 quarters · filed 2024-11-07 | $32.57M 10-Q · filed 2024-11-07 | |||||
| 2023-06-30 | $11.20M 10-Q · filed 2024-08-06 | $23.02M 10-Q · filed 2024-08-06 | ||||||
| 2019-12-31 | $91.21M 10-K · filed 2020-02-24 | $198.69M derived: sum of 2 quarters · filed 2020-02-24 | $288.28M derived: sum of 3 quarters · filed 2020-02-24 | $378.13M 10-K · filed 2020-02-24 | ||||
| 2019-09-30 | $107.48M 10-K · filed 2020-02-24 | $197.07M derived: sum of 2 quarters · filed 2020-02-24 | $286.92M derived: sum of 3 quarters · filed 2020-02-24 | $369.97M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2019-06-30 | $89.59M 10-K · filed 2020-02-24 | $179.44M derived: sum of 2 quarters · filed 2020-02-24 | $262.49M derived: sum of 3 quarters · filed 2020-02-24 | $346.27M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2019-03-31 | $89.85M 10-K · filed 2020-02-24 | $172.90M derived: sum of 2 quarters · filed 2020-02-24 | $256.68M derived: sum of 3 quarters · filed 2020-02-24 | $339.48M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-12-31 | $83.05M 10-K · filed 2020-02-24 | $166.83M derived: sum of 2 quarters · filed 2020-02-24 | $249.63M derived: sum of 3 quarters · filed 2020-02-24 | $326.32M 10-K · filed 2020-02-24 | ||||
| 2018-09-30 | $83.78M 10-K · filed 2020-02-24 | $166.58M derived: sum of 2 quarters · filed 2020-02-24 | $243.27M derived: sum of 3 quarters · filed 2020-02-24 | $318.74M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $82.80M 10-K · filed 2020-02-24 | $159.49M derived: sum of 2 quarters · filed 2020-02-24 | $234.96M derived: sum of 3 quarters · filed 2020-02-24 | $307.46M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $76.69M 10-K · filed 2020-02-24 | $152.17M derived: sum of 2 quarters · filed 2020-02-24 | $224.66M derived: sum of 3 quarters · filed 2020-02-24 | $302.43M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $75.47M 10-K · filed 2019-02-25 | $147.97M derived: sum of 2 quarters · filed 2019-02-25 | $225.74M derived: sum of 3 quarters · filed 2019-02-25 | $299.98M 10-K · filed 2019-02-25 | ||||
| 2017-09-30 | $72.50M 10-K · filed 2019-02-25 | $150.26M derived: sum of 2 quarters · filed 2019-02-25 | $224.50M derived: sum of 3 quarters · filed 2019-02-25 | $302.30M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-06-30 | $77.77M 10-K · filed 2019-02-25 | $152.00M derived: sum of 2 quarters · filed 2019-02-25 | $229.81M derived: sum of 3 quarters · filed 2019-02-25 | $299.15M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-03-31 | $74.24M 10-K · filed 2019-02-25 | $152.04M derived: sum of 2 quarters · filed 2019-02-25 | $221.38M derived: sum of 3 quarters · filed 2019-02-25 | $305.64M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2016-12-31 | $77.80M 10-K · filed 2018-02-26 | $147.15M derived: sum of 2 quarters · filed 2018-02-26 | $231.40M derived: sum of 3 quarters · filed 2018-02-26 | $300.87M 10-K · filed 2018-02-26 | ||||
| 2016-09-30 | $69.35M 10-K · filed 2018-02-26 | $153.60M derived: sum of 2 quarters · filed 2018-02-26 | $223.07M 10-Q · filed 2016-10-31 | $298.90M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $84.25M 10-K · filed 2018-02-26 | $84.20M 10-Q · filed 2016-08-01 | $153.61M 10-Q · filed 2016-08-01 | $229.55M derived: sum of 3 quarters · filed 2018-02-26 | $302.70M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2016-03-31 | $69.47M 10-K · filed 2018-02-26 | $69.42M 10-Q · filed 2016-04-28 | $145.30M derived: sum of 2 quarters · filed 2018-02-26 | $218.44M derived: sum of 3 quarters · filed 2018-02-26 | $292.56M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2015-12-31 | $75.83M 10-K · filed 2017-02-27 | $148.98M derived: sum of 2 quarters · filed 2017-02-27 | $223.09M derived: sum of 3 quarters · filed 2017-02-27 | $300.71M 10-K · filed 2017-02-27 | ||||
| 2015-09-30 | $73.15M 10-K · filed 2017-02-27 | $147.26M derived: sum of 2 quarters · filed 2017-02-27 | $224.88M 10-Q · filed 2016-10-31 | $299.75M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $74.12M 10-K · filed 2017-02-27 | $151.73M 10-Q · filed 2016-08-01 | $226.60M derived: sum of 3 quarters · filed 2017-02-27 | $295.82M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $77.61M 10-K · filed 2017-02-27 | $152.49M derived: sum of 2 quarters · filed 2017-02-27 | $221.71M derived: sum of 3 quarters · filed 2017-02-27 | $290.57M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $74.87M 10-K · filed 2016-02-29 | $144.09M derived: sum of 2 quarters · filed 2016-02-29 | $212.96M derived: sum of 3 quarters · filed 2016-02-29 | $286.23M 10-K · filed 2016-02-29 | ||||
| 2014-09-30 | $69.22M 10-K · filed 2016-02-29 | $138.09M derived: sum of 2 quarters · filed 2016-02-29 | $211.35M 10-Q · filed 2015-11-03 | $293.20M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $68.87M 10-K · filed 2016-02-29 | $142.14M 10-Q · filed 2015-08-04 | $223.98M derived: sum of 3 quarters · filed 2016-02-29 | $304.82M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $73.27M 10-K · filed 2016-02-29 | $76.25M 10-Q · filed 2014-05-08 | $155.11M derived: sum of 2 quarters · filed 2016-02-29 | $235.96M derived: sum of 3 quarters · filed 2016-02-29 | $304.79M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $81.84M 10-K · filed 2015-04-29 | $80.00M 10-K · filed 2014-03-31 | $162.69M derived: sum of 2 quarters · filed 2015-04-29 | $231.52M derived: sum of 3 quarters · filed 2015-04-29 | $301.89M 10-K · filed 2016-02-29 | $303.32M 10-K · filed 2014-03-31 | ||
| 2013-09-30 | $80.84M 10-K · filed 2015-04-29 | $84.42M 10-Q · filed 2014-03-25 | $149.68M derived: sum of 2 quarters · filed 2015-04-29 | $220.05M 10-Q · filed 2015-03-31 | $223.32M 10-Q · filed 2014-03-25 | $282.39M derived: sum of 4 quarters · filed 2015-04-29 | ||
| 2013-06-30 | $68.84M 10-K · filed 2015-04-29 | $69.23M 10-Q · filed 2014-03-24 | $139.21M 10-Q · filed 2015-03-31 | $138.90M 10-Q · filed 2014-03-24 | $201.54M derived: sum of 3 quarters · filed 2015-04-29 | $265.53M derived: sum of 4 quarters · filed 2015-04-29 | ||
| 2013-03-31 | $70.37M 10-K · filed 2015-04-29 | $73.53M 10-Q · filed 2013-05-09 | $132.71M derived: sum of 2 quarters · filed 2015-04-29 | $196.70M derived: sum of 3 quarters · filed 2015-04-29 | $266.73M derived: sum of 4 quarters · filed 2015-04-29 | |||
| 2012-12-31 | $62.34M 10-K/A · filed 2015-03-31 | $66.81M 10-K/A · filed 2014-03-24 | $126.33M derived: sum of 2 quarters · filed 2015-03-31 | $196.36M derived: sum of 3 quarters · filed 2015-03-31 | $264.59M 10-K · filed 2015-04-29 | $286.82M 10-K · filed 2013-03-01 | ||
| 2012-09-30 | $63.99M 10-K/A · filed 2015-03-31 | $70.85M 10-Q · filed 2012-11-02 | $134.02M derived: sum of 2 quarters · filed 2015-03-31 | $205.88M 10-Q · filed 2014-03-25 | $217.77M 10-Q · filed 2012-11-02 | $285.42M derived: sum of 4 quarters · filed 2015-03-31 | ||
| 2012-06-30 | $70.04M 10-K/A · filed 2015-03-31 | $75.25M 10-Q · filed 2012-07-30 | $141.22M 10-Q · filed 2014-03-24 | $146.92M 10-Q · filed 2012-07-30 | $221.43M derived: sum of 3 quarters · filed 2015-03-31 | $288.85M derived: sum of 4 quarters · filed 2015-03-31 | ||
| 2012-03-31 | $68.23M 10-K/A · filed 2015-03-31 | $88.22M 10-Q · filed 2012-05-04 | $151.39M derived: sum of 2 quarters · filed 2015-03-31 | $218.81M derived: sum of 3 quarters · filed 2015-03-31 | $291.91M derived: sum of 4 quarters · filed 2015-03-31 | |||
| 2011-12-31 | $83.17M 10-K/A · filed 2014-03-24 | $150.58M derived: sum of 2 quarters · filed 2014-03-24 | $223.68M derived: sum of 3 quarters · filed 2014-03-24 | $332.49M 10-K/A · filed 2015-03-31 | $407.28M 10-K · filed 2012-02-29 | |||
| 2011-09-30 | $67.42M 10-K/A · filed 2014-03-24 | $85.70M 10-Q · filed 2011-10-31 | $140.52M derived: sum of 2 quarters · filed 2014-03-24 | $262.16M 10-Q · filed 2012-11-02 | $307.86M 10-Q · filed 2011-10-31 | $307.50M derived: sum of 4 quarters · filed 2014-03-24 | ||
| 2011-06-30 | $73.10M 10-K/A · filed 2014-03-24 | $90.29M 10-Q · filed 2011-08-05 | $192.31M 10-Q · filed 2012-07-30 | $222.15M 10-Q · filed 2011-08-05 | $240.08M derived: sum of 3 quarters · filed 2014-03-24 | $327.72M derived: sum of 4 quarters · filed 2014-03-24 | ||
| 2011-03-31 | $116.86M 10-K/A · filed 2014-03-24 | $131.87M 10-Q · filed 2012-05-04 | $166.98M derived: sum of 2 quarters · filed 2014-03-24 | $254.62M derived: sum of 3 quarters · filed 2014-03-24 | $342.17M derived: sum of 4 quarters · filed 2014-03-24 | |||
| 2010-12-31 | $50.12M derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-03-24 | $137.76M derived: sum of 2 quarters · filed 2014-03-24 | $225.31M derived: sum of 3 quarters · filed 2014-03-24 | $299.49M 10-K/A · filed 2014-03-24 | $343.66M 10-K · filed 2012-02-29 | |||
| 2010-09-30 | $87.65M 10-Q · filed 2011-10-31 | $175.19M derived: sum of 2 quarters · filed 2011-10-31 | $249.38M 10-Q · filed 2011-10-31 | |||||
| 2010-06-30 | $87.55M 10-Q · filed 2011-08-05 | $161.73M 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $343.31M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |